Scientific elaboration of selected aspects of the generation and analysis of routine practice data for benefit assessments of drugs according to §35a of the German Social Code Book V (SGB V)

Report documents

1. Extract of the rapid report

   Scientific elaboration of selected aspects of the generation and analysis of routine practice data for benefit assessments of drugs according to §35a of the German Social Code Book V (SGB V)

   published on

   25.11.2025

   Document type

   PDF document, 1 MB, EN, not accessible

   DOI-Link

   https://doi.org/10.60584/A25-13_en

   Download file : Extract of the rapid report (PDF document, 1 MB, EN, not accessible)
2. Rapid Report

   Scientific elaboration of selected aspects of the generation and analysis of routine practice data for benefit assessments of drugs according to §35a of the German Social Code Book V (SGB V)

   published on

   25.11.2025

   Document type

   PDF document, 2 MB, DE, not accessible

   DOI-Link

   https://doi.org/10.60584/A25-13

   Download file : Rapid Report (PDF document, 2 MB, DE, not accessible)
3. Documentation of comments on the preliminary rapid report

   Scientific elaboration of selected aspects of the generation and analysis of routine practice data for benefit assessments of drugs according to §35a of the German Social Code Book V (SGB V)

   published on

   25.11.2025

   Document type

   PDF document, 3 MB, DE, not accessible

   Download file : Documentation of comments on the preliminary rapid report (PDF document, 3 MB, DE, not accessible)
4. Preliminary rapid report

   Scientific elaboration of selected aspects of the generation and analysis of routine practice data for benefit assessments of drugs according to §35a of the German Social Code Book V (SGB V)

   published on

   30.07.2025

   Document type

   PDF document, 1 MB, DE, not accessible

   Download file : Preliminary rapid report (PDF document, 1 MB, DE, not accessible)

Press releases

Project details

Project no.

A25-13

Commission

Commission awarded on 28.01.2025 by the Federal Joint Committee (GBA).

Report type

Rapid report

Status

Commission completed

Department/Division

Drug Assessment

DOI

https://doi.org/10.60584/A25-13_en